Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
BULLISH SIGNAL DETECTED · Alpha
██.█% Sign up free to reveal

Ascendis Pharma A/S (ASND) AI Forecast

Our AI ranks Ascendis Pharma A/S outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

✓ Free account • ✓ 30-day free trial

$ASND Bullish Signal Full forecast available
Sign Up Free

Ascendis Pharma A/S (ASND) Stock Forecast Sept. 24, 2026

Ascendis Pharma A/S (ASND) AI Stock Price Forecast & Investment Analysis

Ascendis Pharma A/S Stock Price Chart and Technical Analysis

Loading chart...

Ascendis Pharma A/S (ASND) - Comprehensive Stock Analysis & Investment Research

Deep dive into Ascendis Pharma A/S's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on September 24, 2026 (UTC)

Ascendis Pharma A/S Investment Summary

When evaluating whether Ascendis Pharma A/S (ASND) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Ascendis Pharma A/S (ASND) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $14 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Ascendis Pharma A/S's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Ascendis Pharma A/S along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Ascendis Pharma A/S is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Ascendis Pharma A/S

Sign Up Free
Corporate Identity

Ascendis Pharma A/S (Stock Symbol: ASND) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Ascendis Pharma A/S's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Ascendis Pharma A/S...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Ascendis Pharma A/S...

Unlock Full Company Profile

Get complete details about Ascendis Pharma A/S

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Ascendis Pharma A/S...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Ascendis Pharma A/S...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Ascendis Pharma A/S...

Unlock Financial Analysis

Get complete financial metrics for Ascendis Pharma A/S

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Ascendis Pharma A/S's AI Price Forecast

Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

4537 Stocks in the out-of-sample test
73.7% Rebalance periods with a positive net return
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Ascendis Pharma A/S strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Ascendis Pharma A/S competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Financial Strength & Leverage

Ascendis Pharma A/S (ASND) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Ascendis Pharma A/S stock analysis. Financial statement data is not available for this company: its filings are not in a form the pipeline converts, so only market data is shown.

Deep dive into Ascendis Pharma A/S's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Ascendis Pharma A/S stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Ascendis Pharma A/S:

Market Cap $14.30B
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Ascendis Pharma A/S converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Ascendis Pharma A/S:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess Ascendis Pharma A/S's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Ascendis Pharma A/S:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Ascendis Pharma A/S's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Ascendis Pharma A/S:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Ascendis Pharma A/S uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Ascendis Pharma A/S:

Understanding Financial Statement Data

What these metrics mean: Key figures from Ascendis Pharma A/S's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Ascendis Pharma A/S:

Income Statement
Balance Sheet Highlights (USD millions)
Dividend & Shareholder Information
Shares Outstanding 62M

Latest Ascendis Pharma A/S Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Ascendis Pharma A/S (ASND) stock price and investment outlook.

📰 Loading...

Where ASND sits on the market map

Explore the map →

Ascendis Pharma A/S Industry Peers - Pharmaceutical Preparations

Companies classified under the same SEC industry code as Ascendis Pharma A/S (Pharmaceutical Preparations): 60 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Company Ticker Symbol 90-Day AI Forecast (Alpha) Market Cap (USD M) P/E Ratio P/B Ratio
ASND ██% $14.30B x x
LLY ██% $1.08T 40.6x 110.2x
JNJ ██% $648.67B 30.8x 7.6x
ONC ██% $539.52B x 104.3x
ABBV ██% $468.43B 74.2x x
MRK ██% $365.34B 115.1x 8.7x
NVS ██% $272.31B x x
GSK ██% $214.26B x x
ABT ██% $180.26B 28.6x 3.5x
PFE ██% $160.62B 37.1x 1.9x
VRTX ██% $130.87B 29.7x 6.5x
BMY ██% $125.63B 13.5x 5.6x
REGN ██% $82.55B 19.1x 2.6x
SNY ██% $50.80B x x
TEVA ██% $45.46B 64.3x 5.9x
ALNY ██% $33.40B x 24.7x
RPRX ██% $33.15B 40.7x 4.9x
ATHE ██% $32.40B x x
TAK ██% $29.93B x x
ZLAB ██% $29.68B x 48.9x
ZTS ██% $29.59B 11.3x 9.4x
ROIV ██% $26.60B x 6.3x
INSM ██% $25.84B x 34.1x
UTHR ██% $20.99B 16.0x 3.3x
VTRS ██% $19.66B x x
JAZZ ██% $15.25B 16.2x 3.2x
SMMT ██% $13.12B x 20.8x
BBIO ██% $12.96B x x
CORT ██% $12.81B x 18.2x
HCM ██% $12.54B x 10.1x
BMRN ██% $11.88B x 1.9x
KNSA ██% $11.87B x 19.6x
MDGL ██% $11.85B x 22.6x
ELAN ██% $11.17B x 1.7x
RDY ██% $10.34B x x
AXSM ██% $10.27B x 123.3x
ARWR ██% $9.33B x 20.1x
CYTK ██% $9.13B x x
PTGX ██% $8.98B x 10.7x
PRAX ██% $7.88B x 5.9x
SYRE ██% $7.77B x 7.1x
GPCR ██% $7.71B x 5.7x
ABVX ██% $7.39B x x
IONS ██% $7.30B x 16.6x
ALKS ██% $6.84B x 3.8x
LEGN ██% $6.82B x x
RYTM ██% $6.76B x 65.7x
BLRX ██% $6.68B x x
BLTE ██% $6.67B x 8.7x
AMRX ██% $6.32B x x
LQDA ██% $6.04B x 31.0x
LGND ██% $5.95B 30.2x 6.2x
MIRM ██% $5.80B x x
AMRN ██% $5.64B x 12.7x
TVTX ██% $5.64B x 230.0x
COGT ██% $5.45B x 10.2x
PTCT ██% $5.20B x x
ERAS ██% $5.08B x 14.0x
DNTH ██% $5.07B x 4.3x
VKTX ██% $4.86B x 11.9x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Ascendis Pharma A/S Stock Forecast

How accurate are Ascendis Pharma A/S stock predictions?

A per-ticker accuracy statistic for ASND is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

What factors influence Ascendis Pharma A/S stock price forecasts?

Our analysis considers Ascendis Pharma A/S's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Ascendis Pharma A/S a good investment in 2026?

Based on our AI analysis, Ascendis Pharma A/S shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Ascendis Pharma A/S forecasts updated?

Ascendis Pharma A/S forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on September 24, 2026.

Want a simpler view of Ascendis Pharma A/S?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...